Israeli treatment helps bone marrow transplants

Israeli biotech Enlivex has developed a treatment called ApoCell that triggers a response from the immune system to reduce adverse reactions during bone marrow transplants. It prevents Graft vs Host Disease (GVHD), which affects around 70% of transplant patients.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.